Per Sunlight's Terms of Use, subscription fees are not refundable once incurred, with the exception that medically disqualified patients receive refunds for unused months
The Endocrine Society's 2024 clinical practice guideline on pharmacological management of obesity recommends anti-obesity medications as an adjunct to lifestyle modification for patients with BMI of 30 or greater, or 27 or greater with comorbidities
Who Is a Good Candidate for the Redefine Weight Loss Program
Excessive body weight has been linked to a host of comorbidities, including diabetes, cardiovascular diseases (CVDs), cancers, gut metabolite imbalances, and increased susceptibility to pathogen-derived infections
Retatrutide (LY3437943) represents a paradigm shift from dual GLP-1/GIP agonists to a triple-receptor agonist , uniquely targeting GIP, GLP-1, and glucagon receptors